Clinical Trials for Hepatocellular Carcinoma

Find clinical trials for hepatocellular carcinoma. Discover research opportunities and treatment options in your area.

422 Active Trials Found

Showing 422 trials on this page

Page 5 of 22

STRIDE (durvalumab + Tremelimumab) with Lenvatinib Vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

NCT ID: NCT06880523

The STRIDE clinical trial is studying a combination of three medications to see if they can improve treatment outcomes for patients with a type of liver cancer called unresectable hepatocellular ca...

Not yet recruiting

Phase: PHASE2 Type: interventional

A Multicenter Cancer Biospecimen Collection Study

NCT ID: NCT04510129

This clinical trial is focused on collecting tumor samples from patients with specific types of cancer, including head and neck, lung, and breast cancers, among others. The goal is to gather these ...

Type: observational Locations: San Francisco, California, United States

Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma

NCT ID: NCT06864221

This clinical trial is studying how certain substances in the blood, called sphingolipids, might affect the success of radiotherapy in treating liver cancer, specifically hepatocellular carcinoma. ...

Type: observational Locations: Guangzhou, Guangdong, China

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

NCT ID: NCT03895359

This clinical trial is exploring two treatment options for patients with liver cancer, specifically a type called hepatocellular carcinoma. One option is called Transarterial Chemoembolization (TAC...

Phase: PHASE3 Type: interventional Locations: London, Ontario, Canada

Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer

NCT ID: NCT04745390

This clinical trial is looking at two different ways to use a specialized radiation treatment called Stereotactic Body Radiotherapy (SBRT) for patients with liver cancer, specifically hepatocellula...

Phase: NA Type: interventional Locations: London, Ontario, Canada

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

NCT ID: NCT06084481

This clinical trial is studying a new treatment called ABBV-400 for adults with advanced solid tumors, such as liver cancer, pancreatic cancer, and certain types of breast and ovarian cancers. The ...

Phase: PHASE1 Type: interventional Locations: Grand Rapids, Michigan, United States, Durham, North Carolina, United States +64 more

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

NCT ID: NCT05195294

This clinical trial is studying a new treatment for advanced liver cancer related to hepatitis B virus (HBV). Specifically, it looks at a type of immune cell therapy called HBV-TCR T cells (LioCyx-...

Not yet recruiting

Phase: PHASE2 Type: interventional

LTFU for All Cell and Gene Therapy Studies

NCT ID: NCT06194461

This clinical trial, called the LTFU for All Cell and Gene Therapy Studies, is focused on monitoring the long-term safety and tolerability of patients who have received cell or gene therapy treatme...

Not yet recruiting

Type: observational Locations: Washington, District Of Columbia, United States, Rochester, Minnesota, United States +22 more

Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma

NCT ID: NCT06867432

This clinical trial is investigating a new treatment approach for patients with hepatocellular carcinoma (HCC), a type of liver cancer that cannot be surgically removed. The study combines a specia...

Not yet recruiting

Phase: PHASE2 Type: interventional

Abdominal CT Combined With AI for Early Screening of Liver Cancer

NCT ID: NCT06859840

This clinical trial is exploring a new way to detect liver cancer early using advanced imaging techniques combined with artificial intelligence (AI). The study will use CT scans from 10,000 patient...

Not yet recruiting

Phase: NA Type: interventional Locations: Hangzhou, Zhejiang, China

Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma

NCT ID: NCT05304481

This clinical trial is investigating the use of a type of immune cell therapy called Activated T Lymphocytes (ATL) to see if it can help patients with liver cancer, specifically Hepatocellular Carc...

Phase: PHASE2 Type: interventional Locations: Taipei, , Taiwan, Taoyuan, , Taiwan +13 more

Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma

NCT ID: NCT06551272

This clinical trial is investigating whether a special treatment called EXL01, which contains a type of bacteria known as Faecalibacterium prausnitzii, can improve the effectiveness of existing can...

Phase: PHASE2 Type: interventional Locations: Villejuif, , France, Bobigny, , France +2 more

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT ID: NCT06242470

This clinical trial is investigating a new treatment called MGC026 for adults with advanced solid tumors, which are types of cancer that have spread or cannot be removed through surgery. The study ...

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Los Angeles, California, United States +10 more

A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer

NCT ID: NCT06005740

This clinical trial is testing a new treatment called TORL-4-500 in patients with advanced cancer, particularly those with solid tumors like liver cancer. The main goals of the study are to see how...

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Jacksonville, Florida, United States +9 more

Personalized DC Vaccine for Postoperative Cancer

NCT ID: NCT04147078

This clinical trial is studying a new type of treatment called a personalized dendritic cell (DC) vaccine for patients who have recently had surgery for certain types of cancer, including gastric c...

Phase: PHASE1 Type: interventional Locations: Chengdu, Sichuan, China

To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization

NCT ID: NCT06478719

This clinical trial is studying a new drug called FB-1603 to see if it can help improve liver function in patients with hepatocellular carcinoma (a type of liver cancer) who are receiving a treatme...

Phase: PHASE1 Type: interventional Locations: Taipei, , Taiwan

The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)

NCT ID: NCT06789757

This clinical trial is investigating a new treatment approach for patients with hepatocellular carcinoma (HCC), a type of liver cancer. The study is testing a combination of three medications: atez...

Phase: PHASE2 Type: interventional Locations: Falls Church, Virginia, United States

Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma

NCT ID: NCT06405321

This clinical trial is studying the best treatment options for patients with hepatocellular carcinoma (HCC), a type of liver cancer. Researchers are looking at different therapies, such as chemothe...

Type: observational Locations: Nanning, , China

Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients

NCT ID: NCT05629845

This clinical trial is studying two different ways to prevent rebleeding in patients with hepatocellular carcinoma (HCC) who have experienced variceal bleeding (bleeding from swollen veins in the e...

Phase: NA Type: interventional Locations: Sha Tin, New Territories, Hong Kong

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

NCT ID: NCT05992220

This clinical trial is studying a combination treatment for patients with advanced liver cancer, specifically Hepatocellular Carcinoma (HCC) that has spread into the blood vessels within the liver....

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions